4//SEC Filing
Kushner Peter J. 4
Accession 0001209191-20-059973
CIK 0001750284other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:32 PM ET
Size
10.9 KB
Accession
0001209191-20-059973
Insider Transaction Report
Form 4
Kushner Peter J.
Chief Scientific Officer
Transactions
- Conversion
Common Stock
2020-11-23+228,761→ 1,301,513 total - Conversion
Common Stock
2020-11-23+130,159→ 1,431,672 total - Conversion
Series A-1 Convertible Preferred Stock
2020-11-23−130,159→ 0 total→ Common Stock (130,159 underlying) - Conversion
Series A Convertible Preferred Stock
2020-11-23−228,761→ 0 total→ Common Stock (228,761 underlying)
Footnotes (1)
- [F1]The shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock were convertible into Common Stock on a 1:1 basis and had no expiration date. Immediately upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock and Series A-1 Convertible Preferred Stock automatically converted into shares of Common Stock.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831217
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:32 PM ET
- Size
- 10.9 KB